期刊文献+

BRCA1基因与乳腺癌

The Gene of BRCA1 and Breast Carcinoma
原文传递
导出
摘要 乳腺癌易感基因1(BRCA1)是具有遗传倾向的乳腺癌和卵巢癌的易感基因,且是一种抑癌基因。BRCA1基因的突变与家族性乳腺癌及它在细胞周期的调节,DNA损伤修复,基因的转录调控和诱导细胞凋亡方面起着重要作用。BRCAl基因的突变与家族性乳腺癌及卵巢癌的发生密切相关,对BRCA1分子功能的研究,将有利于阐明肿瘤发生的机理关。BRCA1的启动子甲基化与散发性乳腺癌有关。本文拟对BRCA1的结构,功能以及它的甲基化,突变,杂合性丢失对乳腺癌的影响作一综述。 BRCA 1 which a tumor suppressor gene is the susceptibility gene that women are genetically predisposed to breast and ovary cancer.BRCAI mutation is closely associated with occurrence of the family breast and ovary cancer.It not only maintains the cell cycle running normally,and it also regulates cell cycle checkpoint when DNA is damaged.It ensures the nor-mal nitosis through keeping accurate copy of centrosome and form of spindle,and involved in the process of DNA danmification and repair through the interaction with the proteins which are esponsible for DNA damnification and repair in the cells.It has dual functions of transcriptional activation and suppression,and stimulates apoptosis with the interaction with apo-ptosis factors.The research of BRCA 1 function will be helpful to illuminating tumor mech anism.The BRCA1 mutation and familial breast cancer-related.BRCA1 methylation of the promoter has a close relation with sporadic breast carcinomas.cancer-related.This article BRCA1 to be on the structure functions,as well as its methylation,mutation,loss of heterozygosity on the impact of breast cancer are reviewed.
出处 《现代生物医学进展》 CAS 2009年第23期4584-4586,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金(30760072)
关键词 乳腺癌易感基因1 乳腺癌 突变 甲基化 杂合性丢失 BRCA1 Breast cancer Mutation methylation Loss of heterozygosity
  • 相关文献

参考文献28

  • 1Hall JM, Lee MK, Newman B, et al. Linkage of early on set familial breast cancer to chromosome, 17q21 [J]. Science, 1990,250: 1684.
  • 2Narod S A, Foulkes W D. BRCAland BRCA2:1994 and beyond[J]. Nat Rev Cancer, 2004, 4(9): 665-676.
  • 3Jhanwar-Uniyal M. BRCA1 in cancer,cell cycle and genomic stability[J].Front Biosci, 2003, 8:1107-1117.
  • 4Lou Z, Chini C C, Minter D K, et al. Mediator of DNA damage checkpoint protein 1 regulates BRCAI localization and phosphorylation in DNA damage checkpoint control[J]. J Biol Chem, 2003, 278(16): 13599-13603.
  • 5Rosell R, Danenberg K D, Alberola V, et al. Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients [J]. Clin Cancer Res, 2004, 10(22): 1318-1325.
  • 6Taron M, Rosell R, Felip E, et al. BRCA mRNA expression levels as an indicator of chemoresistance in lung cancer [J]. Hum Mol Genet, 2004, 13(20): 2443-2449.
  • 7BEGG C B, HALLE R W, BORG A, et al. Variation of Breast Cancer Risk Among BRCA1/2 Carriers[J]. AMA, 2008,299(2): 194-201.
  • 8JOHN E M, MIRON A, GONG G, et al. Prevalence of pathogenic BRCAI Mutation Carriers in 5 US Racial-Ethnic Groups [J]. JAMA, 2007, 298(24):2869-2876.
  • 9PEREIRA L H, PINEDA M A, ROWE W H, et al. The BRCA1 Ashkenazi founde rmutations occur on common haplotypes highlly correlatted with anonymous single nucleotide polymorphlisms likely to be used ingenome-wide case-control association studies [J]. BMC Genet, 2007,(8):68.
  • 10RUSSO A, CALO V, AUGELO C, et al. 4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy(Sicily) [J]. Ann Oncol, 2007, Suppl 6:vi99-102.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部